PALIPERIDONE PALMITATE |
211149 |
001 |
ANDA |
PALIPERIDONE PALMITATE |
SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
39MG/0.25ML (39MG/0.25ML) |
No
|
No
|
2021/07/06
|
2021/07/06
|
TEVA PHARMS USA |
Prescription |
PALIPERIDONE PALMITATE |
211149 |
002 |
ANDA |
PALIPERIDONE PALMITATE |
SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
78MG/0.5ML (78MG/0.5ML) |
No
|
No
|
2021/07/06
|
2021/07/06
|
TEVA PHARMS USA |
Prescription |
PALIPERIDONE PALMITATE |
211149 |
003 |
ANDA |
PALIPERIDONE PALMITATE |
SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
117MG/0.75ML (117MG/0.75ML) |
No
|
No
|
2021/07/06
|
2021/07/06
|
TEVA PHARMS USA |
Prescription |
PALIPERIDONE PALMITATE |
211149 |
004 |
ANDA |
PALIPERIDONE PALMITATE |
SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
156MG/ML (156MG/ML) |
No
|
No
|
2021/07/06
|
2021/07/06
|
TEVA PHARMS USA |
Prescription |
PALIPERIDONE PALMITATE |
211149 |
005 |
ANDA |
PALIPERIDONE PALMITATE |
SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
234MG/1.5ML (156MG/ML) |
No
|
No
|
2021/07/06
|
2021/07/06
|
TEVA PHARMS USA |
Prescription |
PALIPERIDONE PALMITATE |
211995 |
001 |
ANDA |
PALIPERIDONE PALMITATE |
SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
39MG/0.25ML |
No
|
No
|
2023/06/30
(TA)
|
--
|
TOLMAR |
None (Tentative Approval) |
PALIPERIDONE PALMITATE |
211995 |
002 |
ANDA |
PALIPERIDONE PALMITATE |
SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
78MG/0.5ML |
No
|
No
|
2023/06/30
(TA)
|
--
|
TOLMAR |
None (Tentative Approval) |
PALIPERIDONE PALMITATE |
211995 |
003 |
ANDA |
PALIPERIDONE PALMITATE |
SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
117MG/0.75ML |
No
|
No
|
2023/06/30
(TA)
|
--
|
TOLMAR |
None (Tentative Approval) |
PALIPERIDONE PALMITATE |
211995 |
004 |
ANDA |
PALIPERIDONE PALMITATE |
SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
156MG/ML |
No
|
No
|
2023/06/30
(TA)
|
--
|
TOLMAR |
None (Tentative Approval) |
PALIPERIDONE PALMITATE |
211995 |
005 |
ANDA |
PALIPERIDONE PALMITATE |
SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
234MG/1.5ML |
No
|
No
|
2023/06/30
(TA)
|
--
|
TOLMAR |
None (Tentative Approval) |
PALIPERIDONE PALMITATE |
210397 |
001 |
ANDA |
PALIPERIDONE PALMITATE |
SUSPENSION;EXTENDED RELEASE |
|
No
|
No
|
2024/02/05
(TA)
|
--
|
PHARMASCIENCE INC |
None (Tentative Approval) |
PALIPERIDONE PALMITATE |
216228 |
001 |
ANDA |
PALIPERIDONE PALMITATE |
SUSPENSION, EXTENDED RELEASE;INJECTABLE |
273MG/0.88ML |
No
|
No
|
2024/05/20
(TA)
|
--
|
MYLAN PHARMS INC |
None (Tentative Approval) |